Finally, the lower level of s-IGF-II in cardioembolic stroke abided after stratifying for stroke severity and CRP (data not shown), as well as remaining significant after 3 months, which argues against the notion that this finding merely reflects an acute stress response. The gene discussed is IGF2; the disease is stroke disorder.